Regulation (EU) 2017/745
Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (Text with EEA relevance. )
In forceTyperegulationDate5 Apr 2017Since29 Dec 2017Articles124Versions held263Cited by387 documentsLast changed9 Nov 2026
- 5Placing on the market and putting into service
- 6Distance sales
- 7Claims
- 8Use of harmonised standards
- 9Common specifications
- 10General obligations of manufacturers
- 10aObligations in case of interruption or discontinuation of supply of certain devices
- 11Authorised representative
- 12Change of authorised representative
- 13General obligations of importers
- 14General obligations of distributors
- 15Person responsible for regulatory compliance
- 16Cases in which obligations of manufacturers apply to importers, distributors or other persons
- 17Single-use devices and their reprocessing
- 18Implant card and information to be supplied to the patient with an implanted device
- 19EU declaration of conformity
- 20CE marking of conformity
- 21Devices for special purposes
- 22Systems and procedure packs
- 23Parts and components
- 24Free movement
- 25Identification within the supply chain
- 26Medical devices nomenclature
- 27Unique Device Identification system
- 28UDI database
- 29Registration of devices
- 30Electronic system for registration of economic operators
- 31Registration of manufacturers, authorised representatives and importers
- 32Summary of safety and clinical performance
- 33European database on medical devices
- 34Functionality of Eudamed
- 35Authorities responsible for notified bodies
- 36Requirements relating to notified bodies
- 37Subsidiaries and subcontracting
- 38Application by conformity assessment bodies for designation
- 39Assessment of the application
- 40Nomination of experts for joint assessment of applications for notification
- 41Language requirements
- 42Designation and notification procedure
- 43Identification number and list of notified bodies
- 44Monitoring and re-assessment of notified bodies
- 45Review of notified body assessment of technical documentation and clinical evaluation documentation
- 46Changes to designations and notifications
- 47Challenge to the competence of notified bodies
- 48Peer review and exchange of experience between authorities responsible for notified bodies
- 49Coordination of notified bodies
- 50List of standard fees
SECTION 2 Conformity assessment
- 52Conformity assessment procedures
- 53Involvement of notified bodies in conformity assessment procedures
- 54Clinical evaluation consultation procedure for certain class III and class IIb devices
- 55Mechanism for scrutiny of conformity assessments of certain class III and class IIb devices
- 56Certificates of conformity
- 57Electronic system on notified bodies and on certificates of conformity
- 58Voluntary change of notified body
- 59Derogation from the conformity assessment procedures
- 60Certificate of free sale
- 61Clinical evaluation
- 62General requirements regarding clinical investigations conducted to demonstrate conformity of devices
- 63Informed consent
- 64Clinical investigations on incapacitated subjects
- 65Clinical investigations on minors
- 66Clinical investigations on pregnant or breastfeeding women
- 67Additional national measures
- 68Clinical investigations in emergency situations
- 69Damage compensation
- 70Application for clinical investigations
- 71Assessment by Member States
- 72Conduct of a clinical investigation
- 73Electronic system on clinical investigations
- 74Clinical investigations regarding devices bearing the CE marking
- 75Substantial modifications to clinical investigations
- 76Corrective measures to be taken by Member States and information exchange between Member States
- 77Information from the sponsor at the end of a clinical investigation or in the event of a temporary halt or
- 78Coordinated assessment procedure for clinical investigations
- 79Review of coordinated assessment procedure
- 80Recording and reporting of adverse events that occur during clinical investigations
- 81Implementing acts
- 82Requirements regarding other clinical investigations
SECTION 1 Post-market surveillance
- 93Market surveillance activities
- 94Evaluation of devices suspected of presenting an unacceptable risk or other non-compliance
- 95Procedure for dealing with devices presenting an unacceptable risk to health and safety
- 96Procedure for evaluating national measures at Union level
- 97Other non-compliance
- 98Preventive health protection measures
- 99Good administrative practice
- 100Electronic system on market surveillance
- 114Committee procedure
- 115Exercise of the delegation
- 116Separate delegated acts for different delegated powers
- 117Amendment to Directive 2001/83/EC
- 118Amendment to Regulation (EC) No 178/2002
- 119Amendment to Regulation (EC) No 1223/2009
- 120Transitional provisions
- 121Evaluation
- 122Repeal
- 123Entry into force and date of application
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).